Non-competitive inhibitors bind allosteric sites away from active sites, changing enzyme shape and reducing catalytic activity despite substrate presence in reactions.
Coverage 2012–2024 · Updated 15 Jul 2026
An allosteric site is a specific regulatory binding site separate from the active site; reversible inhibitor binding there can produce non-competitive inhibition.
Only molecules with suitable interactions bind the allosteric site. Binding changes interactions within the enzyme and causes a conformational change that alters the active site enough to prevent or reduce catalysis.
Because the inhibitor does not compete for the active site, adding more substrate does not fully restore activity. When the inhibitor dissociates, the enzyme can return to its active conformation.
If maximum rate remains lower at high substrate concentration in the presence of a reversible allosteric inhibitor, the pattern is consistent with non-competitive inhibition.
Non-competitive does not mean irreversible or nonspecific. The inhibitor binds a specific separate site and affects activity through conformation.
This objective is assessed through structured response, commonly using Describe / Explain / Deduce.
Describe / Explain / Deduce / Outline / Compare / Distinguish
Build the answer around this relationship: Non-competitive inhibitors bind away from the active site.
Representative question
Explain how a non-competitive inhibitor such as copper causes a reduction in enzyme activity.
Enzymes can act inside or outside cells, metabolic reactions release heat, pathways may be linear or cyclical, and pathway output is regulated by inhibition. Competitive inhibitors bind active sites and can be overcome by more substrate; non-competitive inhibitors bind allosteric sites; feedback inhibition uses end products to inhibit earlier enzymes; mechanism-based inhibitors trap enzymes after reaction begins.
